Condition

HER2 Expressing Solid Tumors clinical trials and research

• 2Clinical trials
• 2Countries

All recruiting trials (2)

• Testing MT-304, an mRNA lipid-nanoparticle anti-HER2 CAR therapy, in adults with advanced HER2-expressing solid tumors.

  This will test MT-304, given alone or with nivolumab, in adults with advanced HER2-expressing solid tumors to find a safe dose and look for early signs of benefit.

  Recruiting at 7 sites Phase 1 Myeloid Therapeutics · Darlinghurst, New South Wales and 6 other locations · NCT07334119

• VNX-202 gene therapy for HER2-positive solid tumors

  This study will test a one-time IV gene therapy (VNX-202) that instructs the liver to produce a HER2-targeting protein to treat adults with HER2-positive solid tumors who have had prior therapy or are at high risk of relapse.

  Recruiting at 11 sites Phase 1/2 Vironexis Biotherapeutics Inc. · Los Angeles, California and 10 other locations · NCT07192432

Quick answers

How many HER2 Expressing Solid Tumors clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →